PPARδ agonist 8

• Description :

  Pparδ agonist 8 is a potent agonist of Pparδ. The peroxisome proliferator-activated receptor (PPAR) is a member of the intranuclear receptor transcription factor superfamily that plays a key role in the regulation of metabolic homeostasis, inflammation, cell growth and differentiation in vivo. Pparδ agonist 8 has the potential for the research of non-alcoholic fatty liver disease (NAFLD) (extracted from patent WO2021169769A1, compound TM2) [1].

• UNSPSC :

  12352005

• Target :

  PPAR

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Metabolic Disease

• Assay Protocol :

  https://www.medchemexpress.com/pparδ-agonist-8.html

• Solubility :

  10 mM in DMSO

• Smiles :

  CC(C)(OC1=C(C)C=C(CCC(O)C2=CC3=CC=CC=C3N=C2OC)C=C1C)C(O)=O

• Molecular Formula :

  C25H29NO5

• Molecular Weight :

  423.50

• References & Citations :

  [1]Shoujun Chen, et al. Aromatic compounds and pharmaceutical compositions and uses thereof. Patent WO2021169769A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2697129-55-6]